The DOI matches its Crossref record; 403 of the 403 references it cites were found in a registry or an index.
An Inflammation-Centric View of Neurological Disease: Beyond the Neuron
Open accessAbstract
Inflammation is a complex biological response fundamental to how the body deals with injury and infection to eliminate the initial cause of cell injury and effect repair. Unlike a normally beneficial acute inflammatory response, chronic inflammation can lead to tissue damage and ultimately its destruction, and often results from an inappropriate immune response. Inflammation in the nervous system ('neuroinflammation'), especially when prolonged, can be particularly injurious. While inflammation per se may not cause disease, it contributes importantly to disease pathogenesis across both the peripheral (neuropathic pain, fibromyalgia) and central (e.g. Alzheimer disease, Parkinson disease, multiple sclerosis, motor neuron disease. ischemia and traumatic brain injury, depression, and autism spectrum disorder) nervous systems. The existence of extensive lines of communication between the nervous system and immune system represents a fundamental principle underlying neuroinflammation. Immune cell-derived inflammatory molecules are critical for regulation of host responses to inflammation. Although these mediators can originate from various non-neuronal cells, important sources in the above neuropathologies appear to be microglia and mast cells, together with astrocytes and possibly also oligodendrocytes. Understanding neuroinflammation also requires an appreciation that non-neuronal cell – cell interactions, between both glia and mast cells and glia themselves, are an integral part of the inflammation process. Within this context the mast cell occupies a key niche in orchestrating the inflammatory process, from initiation to prolongation. This review will describe the current state of knowledge concerning the biology of neuroinflammation, emphasizing mast cell-glia and glia-glia interactions, then conclude with a consideration of how a cell’s endogenous mechanisms might be leveraged to provide a therapeutic strategy to target neuroinflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 403
Piette, F., Belmin, J., Vincent, H., Schmidt, N., Pariel, S., Verny, M., Marquis, C., Mely, J., Hugonot-Diener, L., Kinet, J.-P., et al. (2011) · Alzheimer's Research & Therapy · doi:10.1186/alzrt75 · Cited by 173
Case-Control Cohort Study of Patients' Perceptions of Disability in Mastocytosis
Hermine, O., Lortholary, O., Leventhal, P. S., Catteau, A., Soppelsa, F., Baude, C., Cohen-Akenine, A., Palmérini, F., Hanssens, K., Yang, Y., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002266 · Cited by 173
The N‐Acylethanolamine‐Hydrolyzing Acid Amidase (NAAA)
Tsuboi, K., Takezaki, N., & Ueda, N. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790159 · Cited by 172
Theoharides, T. C., Stewart, J. M., Hatziagelaki, E., & Kolaitis, G. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00225 · Cited by 170
Perioperative Cognitive Decline in the Aging Population
Terrando, N., Brzezinski, M., Degos, V., Eriksson, L. I., Kramer, J. H., Leung, J. M., Miller, B. L., Seeley, W. W., Vacas, S., Weiner, M. W., et al. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2011.0332 · Cited by 170
Brain mast cells link the immune system to anxiety-like behavior
Nautiyal, K. M., Ribeiro, A. C., Pfaff, D. W., & Silver, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809479105 · Cited by 167
Neuronal CCL21 up‐regulates microglia P2X4 expression and initiates neuropathic pain development
Biber, K., Tsuda, M., Tozaki‐Saitoh, H., Tsukamoto, K., Toyomitsu, E., Masuda, T., Boddeke, H., & Inoue, K. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.89 · Cited by 166
Palmitoylethanolamide in CNS health and disease
Raso, G. M., Russo, R., Calignano, A., & Meli, R. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.05.006 · Cited by 165
Christy, A. L., Walker, M. E., Hessner, M. J., & Brown, M. A. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.11.003 · Cited by 165
Sayed, B. A., Christy, A. L., Walker, M. E., & Brown, M. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000126 · Cited by 165
Biscaro, B., Lindvall, O., Tesco, G., Ekdahl, C. T., & Nitsch, R. M. (2012) · Neurodegenerative Diseases · doi:10.1159/000330363 · Cited by 164
Carraway, R., Cochrane, D. E., Lansman, J. B., Leeman, S. E., Paterson, B. M., & Welch, H. J. (1982) · The Journal of Physiology · doi:10.1113/jphysiol.1982.sp014080 · Cited by 164
Kim, J., Loggia, M. L., Cahalan, C. M., Harris, R. E., Beissner, F., Garcia, R. G., Kim, H., Barbieri, R., Wasan, A. D., Edwards, R. R., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39043 · Cited by 161
Spinal cord oligodendrocyte‐derived alarmin IL‐33 mediates neuropathic pain
Zarpelon, A. C., Rodrigues, F. C., Lopes, A. H., Souza, G. R., Carvalho, T. T., Pinto, L. G., Xu, D., Ferreira, S. H., Alves‐Filho, J. C., McInnes, I. B., et al. (2016) · The FASEB Journal · doi:10.1096/fj.14-267146 · Cited by 161
The role of the complement system in traumatic brain injury: a review
Hammad, A., Westacott, L., & Zaben, M. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1066-z · Cited by 161
Villapol, S., Byrnes, K. R., & Symes, A. J. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00082 · Cited by 159
Zhang, Q.-S., Heng, Y., Yuan, Y.-H., & Chen, N.-H. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2016.11.002 · Cited by 156
Mast Cell Biology: Introduction and Overview
Gilfillan, A. M., Austin, S. J., & Metcalfe, D. D. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-9533-9_1 · Cited by 155
Zhang, S., Wang, X.-J., Tian, L.-P., Pan, J., Lu, G.-Q., Zhang, Y.-J., Ding, J.-Q., & Chen, S.-D. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-154 · Cited by 154 · cited 2×
“Immunomodulator dysregulation increases microglial activation and the degeneration of dopamine neurons (Zhang et al., 2011).”
BackgroundCerebral Mast Cells Regulate Early Ischemic Brain Swelling and Neutrophil Accumulation
Strbian, D., Karjalainen‐Lindsberg, M., Tatlisumak, T., & Lindsberg, P. J. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600228 · Cited by 153
D’Agostino, G., Rana, G. L., Russo, R., Sasso, O., Iacono, A., Esposito, E., Raso, G. M., Cuzzocrea, S., Verme, J. L., Piomelli, D., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.123265 · Cited by 152
Parkinson’s disease and enhanced inflammatory response
Stojkovska, I., Wagner, B. M., & Morrison, B. E. (2015) · Experimental biology and medicine · doi:10.1177/1535370215576313 · Cited by 145
Relevance of Neuroinflammation and Encephalitis in Autism
Kern, J. K., Geier, D. A., Sykes, L. K., & Geier, M. R. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00519 · Cited by 145
Xu, J., Dong, H., Qian, Q., Zhang, X., Wang, Y., Jin, W., & Qian, Y. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.05.066 · Cited by 144
Mast Cells Are Early Responders After Hypoxia-Ischemia in Immature Rat Brain
Jin, Y., Silverman, A.-J., & Vannucci, S. J. (2009) · Stroke · doi:10.1161/strokeaha.109.549691 · Cited by 143
Mast Cells as Regulators of T Cell Responses
Bulfone‐Paus, S., & Bahri, R. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00394 · Cited by 140
Mast cells promote Th1 and Th17 responses by modulating dendritic cell maturation and function
Dudeck, A., Suender, C. A., Kostka, S. L., von Stebut, E., & Maurer, M. (2011) · European Journal of Immunology · doi:10.1002/eji.201040994 · Cited by 140
The Alarmin HMGB1 Mediates Age-Induced Neuroinflammatory Priming
Fonken, L. K., Frank, M. G., Kitt, M. M., D'Angelo, H. M., Norden, D. M., Weber, M. D., Barrientos, R. M., Godbout, J. P., Watkins, L. R., & Maier, S. F. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.1161-16.2016 · Cited by 139
Hoeijmakers, L., Ruigrok, S. R., Amelianchik, A., Ivan, D., van Dam, A.-M., Lucassen, P. J., & Korosi, A. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.12.023 · Cited by 138 · cited 1×
“…increases in inflammatory responses, Aβ accumulation, tau hyperphosphorylation, oxidative stress, mitochondrial impairment, and glucose metabolism (Machado et al., 2014), while early-life stress increases the risk of cognitive disorders in an aged mouse model of AD (Hoeijmakers et al., 2017).”
BackgroundMast cells, brain inflammation and autism
Theoharides, T. C., Stewart, J. M., Panagiotidou, S., & Melamed, I. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.086 · Cited by 138
Neuroinflammation, Mast Cells, and Glia: Dangerous Liaisons
Skaper, S. D., Facci, L., Zusso, M., & Giusti, P. (2017) · The Neuroscientist · doi:10.1177/1073858416687249 · Cited by 138
Self-citationImpellizzeri, D., Bruschetta, G., Cordaro, M., Crupi, R., Siracusa, R., Esposito, E., & Cuzzocrea, S. (2014) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0136-0 · Cited by 137
Effect of stress on brain inflammation and multiple sclerosis
Karagkouni, A., Alevizos, M., & Theoharides, T. C. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.02.006 · Cited by 135
Immune dysregulation in autism spectrum disorder
Noriega, D. B., & Savelkoul, H. F. J. (2013) · European Journal of Pediatrics · doi:10.1007/s00431-013-2183-4 · Cited by 135
Piirainen, S., Youssef, A. M., Song, C., Kalueff, A. V., Landreth, G. E., Malm, T., & Tian, L. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.01.046 · Cited by 134
The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson's disease
Schapansky, J., Nardozzi, J. D., & LaVoie, M. J. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2014.09.049 · Cited by 132
Action and Traction: Cytoskeletal Control of Receptor Triggering at the Immunological Synapse
Comrie, W. A., & Burkhardt, J. K. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00068 · Cited by 132
Protease-Activated Receptors: How Proteases Signal to Cells to Cause Inflammation and Pain
Bunnett, N. W. (2006) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2006-939553 · Cited by 131
Skaper, S. D., & Facci, L. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0391 · Cited by 129
Self-citationEngler, H., Brendt, P., Wischermann, J., Wegner, A., Rohling, R., Schoemberg, T., Meyer, U., Gold, R., Peters, J., Benson, S., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.264 · Cited by 129
Innate and adaptive immune responses in neurodegeneration and repair
Amor, S., & Woodroofe, M. (2014) · Immunology · doi:10.1111/imm.12134 · Cited by 128
Harnessing the anti-inflammatory potential of palmitoylethanolamide
Alhouayek, M., & Muccioli, G. G. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.06.007 · Cited by 128
Facci, L., Barbierato, M., Marinelli, C., Argentini, C., Skaper, S. D., & Giusti, P. (2014) · Scientific Reports · doi:10.1038/srep06824 · Cited by 128
Self-citationVarrassi, G. (2016) · Pain Physician · doi:10.36076/ppj/2016.19.11 · Cited by 126
Mast cell activation and autism
Theoharides, T. C., Angelidou, A., Alysandratos, K.-D., Zhang, B., Asadi, S., Francis, K., Toniato, E., & Kalogeromitros, D. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.017 · Cited by 125
Gritsch, S., Lu, J., Thilemann, S., Wörtge, S., Möbius, W., Bruttger, J., Karram, K., Ruhwedel, T., Blanfeld, M., Vardeh, D., et al. (2014) · Nature Communications · doi:10.1038/ncomms6472 · Cited by 123
Riedel, B., Browne, K., & SILBERT, B. S. (2013) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000032 · Cited by 122
Interleukin-33 upregulation in peripheral leukocytes and CNS of multiple sclerosis patients
Christophi, G. P., Gruber, R. C., Panos, M., Christophi, R. L., Jubelt, B., & Massa, P. T. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.11.007 · Cited by 122
Spinal microglia are required for long-term maintenance of neuropathic pain
Echeverry, S., Shi, X., Yang, M., Huang, H., Wu, Y., Lorenzo, L.-É., Pérez-Sánchez, J., Bonin, R. P., Koninck, Y. D., & Zhang, J. (2017) · Pain · doi:10.1097/j.pain.0000000000000982 · Cited by 122
The immunomodulatory oligodendrocyte
Zeis, T., Enz, L., & Schaeren-Wiemers, N. (2016) · Brain Research · doi:10.1016/j.brainres.2015.09.021 · Cited by 120
CCL5 induces a pro-inflammatory profile in microglia in vitro
Škuljec, J., Sun, H., Pul, R., Bénardais, K., Ragancokova, D., Moharregh-Khiabani, D., Kotsiari, A., Trebst, C., & Stangel, M. (2011) · Cellular Immunology · doi:10.1016/j.cellimm.2011.05.001 · Cited by 118
Taib, T., Leconte, C., Steenwinckel, J. V., Cho, A. H., Palmier, B., Torsello, E., Lai–Kuen, R., Onyeomah, S., Ecomard, K., Benedetto, C., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184811 · Cited by 116
Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: A phase 2a study
Paul, C. F., Sans, B., Suárez, F., Casassus, P., Barète, S., Lanternier, F., Grandpeix‐Guyodo, C., Dubreuil, P. C., Palmérini, F., Mansfield, C. D., et al. (2010) · American Journal of Hematology · doi:10.1002/ajh.21894 · Cited by 114
Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain
Skaper, S. D., Facci, L., Fusco, M., della Valle, M. F., Zusso, M., Costa, B., & Giusti, P. (2013) · Inflammopharmacology · doi:10.1007/s10787-013-0191-7 · Cited by 113
Self-citationP2 receptor-mediated signaling in mast cell biology
Bulanova, E., & Bulfone‐Paus, S. (2009) · Purinergic Signalling · doi:10.1007/s11302-009-9173-z · Cited by 113
Li, M., Li, Y., Liu, X., Gao, X., & Wang, Y. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.03.016 · Cited by 111
Regulatory T Cells Enhance Mast Cell Production of IL-6 via Surface-Bound TGF-β
Ganeshan, K., & Bryce, P. J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102389 · Cited by 107
Fidaleo, M., Fanelli, F., Cerù, M. P., & Moreno, S. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140303143455 · Cited by 106
Sasso, O., Moreno‐Sanz, G., Martucci, C., Realini, N., Dionisi, M., Mengatto, L., Duranti, A., Tarozzo, G., Tarzia, G., Mor, M., et al. (2012) · Pain · doi:10.1016/j.pain.2012.10.018 · Cited by 106
Thuc, O. L., Blondeau, N., Nahon, J., & Rovère, C. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12855 · Cited by 105
Martini, R., & Willison, H. J. (2015) · Glia · doi:10.1002/glia.22899 · Cited by 105
Öhrfelt, A., Axelsson, M., Malmeström, C., Novakova, L., Heslegrave, A., Blennow, K., Lycke, J., & Zetterberg, H. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458515624558 · Cited by 105
Bertolino, B., Crupi, R., Impellizzeri, D., Bruschetta, G., Cordaro, M., Siracusa, R., Esposito, E., & Cuzzocrea, S. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12648 · Cited by 105
Microglial Priming as Trained Immunity in the Brain
Haley, M. J., Brough, D., Quintin, J., & Allan, S. M. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2017.12.039 · Cited by 104
The role of mast cells in neuroinflammation
Nelissen, S., Lemmens, E., Geurts, N., Kramer, P. P. G., Maurer, M., Hendriks, J. J. A., & Hendrix, S. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1092-y · Cited by 102
Cell-cell cooperation at the T helper cell/mast cell immunological synapse
Gaudenzio, N., Espagnolle, N., Mars, L. T., Liblau, R., Valitutti, S., & Espinosa, É. (2009) · Blood · doi:10.1182/blood-2009-02-202648 · Cited by 102
Microemboli Composed of Cholesterol Crystals Disrupt the Blood-Brain Barrier and Reduce Cognition
Rapp, J. H., Pan, X. M., Neumann, M., Hong, M., Hollenbeck, K., & Liu, J. (2008) · Stroke · doi:10.1161/strokeaha.107.496737 · Cited by 102
Hains, L. E., Loram, L. C., Weiseler, J. L., Frank, M. G., Bloss, E. B., Sholar, P. W., Taylor, F. R., Harrison, J. A., Martin, T. J., Eisenach, J. C., et al. (2010) · Journal of Pain · doi:10.1016/j.jpain.2010.01.271 · Cited by 102
Systematic Review of Pharmacological Properties of the Oligodendrocyte Lineage
Marinelli, C., Bertalot, T., Zusso, M., Skaper, S. D., & Giusti, P. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00027 · Cited by 102
Self-citationErtürk, A., Mentz, S., Stout, E. E., Hedehus, M., Domínguez, S. L., Neumaier, L., Krammer, F., Llovera, G., Srinivasan, K., Hansen, D. V., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1898-15.2016 · Cited by 101
Stroke Study Group, Caltagirone, C., Cisari, C., Schievano, C., Paola, R. D., Cordaro, M., Bruschetta, G., Esposito, E., & Cuzzocrea, S. (2015) · Translational Stroke Research · doi:10.1007/s12975-015-0440-8 · Cited by 100
Targeting IL-33 in Autoimmunity and Inflammation
Theoharides, T. C., Petra, A. I., Taracanova, A., Panagiotidou, S., & Conti, P. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.222505 · Cited by 99
Brenner, T., Soffer, D., Shalit, M., & Levi‐Schaffer, F. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90300-x · Cited by 99
Mattila, O. S., Strbian, D., Saksi, J., Pikkarainen, T. O., Rantanen, V., Tatlisumak, T., & Lindsberg, P. J. (2011) · Stroke · doi:10.1161/strokeaha.111.632224 · Cited by 99
Long-term intracerebral inflammatory response after experimental focal brain injury in rat
Holmin, S., & Mathiesen, T. I. (1999) · Neuroreport · doi:10.1097/00001756-199906230-00017 · Cited by 98
A focus on mast cells and pain
Héron, A., & Dubayle, D. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.09.018 · Cited by 97
Zhang, S., Dong, H., Zhang, X., Li, N., Sun, J., & Qian, Y. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.11.003 · Cited by 96
Kerstman, E. L., Ahn, S., Battu, S., Tariq, S., & Grabois, M. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52901-5.00015-0 · Cited by 96
A tryptophan metabolite, kynurenine, promotes mast cell activation through aryl hydrocarbon receptor
Kawasaki, H., Chang, H. ‐., Tseng, H.-C., Hsu, S., Yang, S. ‐., Hung, C. ‐., Zhou, Y., & Huang, S. (2014) · Allergy · doi:10.1111/all.12346 · Cited by 95
Levy, D., Kainz, V., Burstein, R., & Strassman, A. M. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.09.016 · Cited by 95
Zaheer, A., Zaheer, S. A., Sahu, S. K., Knight, S., Khosravi, H., Mathur, S. N., & Lim, R. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04385.x · Cited by 94
Florenzano, F., & Bentivoglio, M. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20000904)424:4<651::aid-cne7>3.0.co;2-g · Cited by 93
Dong, H., Zhang, X., Wang, Y., Zhou, X., Qian, Y., & Zhang, S. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9720-x · Cited by 93
Heilablóðþurrð / heiladrep. Faraldsfræði, orsakir og einkenni
Sveinsson, O. A., Sveinsson, O. A., Kjartansson, Ó., & Valdimarsson, E. M. (2014) · Læknablaðið · doi:10.17992/lbl.2014.05.543 · Cited by 93
Should We Stop Saying ‘Glia’ and ‘Neuroinflammation’?
Masgrau, R., Guaza, C., Ransohoff, R. M., & Galea, E. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.04.005 · Cited by 93
The crucial role of mast cells in blood–brain barrier alterations
Ribatti, D. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.05.013 · Cited by 92
Rapid and Widespread Microglial Activation Induced by Traumatic Brain Injury in Rat Brain Slices
Koshinaga, M., Katayama, Y., Fukushima, M., Oshima, H., Suma, T., & Takahata, T. (2000) · Journal of Neurotrauma · doi:10.1089/neu.2000.17.185 · Cited by 92
Persistence of Disability 24 to 36 Months after Pediatric Traumatic Brain Injury: A Cohort Study
Rivara, F. P., Vavilala, M. S., Durbin, D. R., Temkin, N. R., Wang, J., O’Connor, S. S., Koepsell, T. D., Dorsch, A. M., & Jaffe, K. M. (2012) · Journal of Neurotrauma · doi:10.1089/neu.2012.2434 · Cited by 92
Mast cells' involvement in inflammation pathways linked to depression: evidence in mastocytosis
Georgin‐Lavialle, S., Moura, D. S., Salvador, A., Chauvet‐Gélinier, J., Launay, J., Damaj, G. L., Côté, F., Soucie, E. L., Chandesris, M., Barète, S., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.216 · Cited by 92
Scuderi, C., Bronzuoli, M. R., Facchinetti, R., Pace, L., Ferraro, L., Broad, K. D., Serviddio, G., Bellanti, F., Palombelli, G., Carpinelli, G., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-017-0076-4 · Cited by 89
Mast Cell Stabilization Limits Hypoxic-Ischemic Brain Damage in the Immature Rat
Jin, Y., Silverman, A., & Vannucci, S. J. (2007) · Developmental Neuroscience · doi:10.1159/000105478 · Cited by 88
Juremalm, M., Hjertson, M., Olsson, N., Harvima, I. T., Nilsson, K., & Nilsson, G. P. (2000) · European Journal of Immunology · Cited by 88
Role of Mast Cells in Male Chronic Pelvic Pain
Done, J. D., Rudick, C. N., Quick, M. L., Schaeffer, A. J., & Thumbikat, P. (2012) · The Journal of Urology · doi:10.1016/j.juro.2011.11.116 · Cited by 87
McKittrick, C. M., Lawrence, C. E., & Carswell, H. V. O. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.239 · Cited by 86
Hoeijmakers, L., Heinen, Y., van Dam, A.-M., Lucassen, P. J., & Korosi, A. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00398 · Cited by 85
Autism Spectrum Disorders and Mastocytosis
Theoharides, T. C. (2009) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200902200401 · Cited by 85
Novel therapeutic targets for autism
Theoharides, T. C., Doyle, R., Francis, K., Conti, P., & Kalogeromitros, D. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.06.002 · Cited by 85
Kim, D. Y., Hong, G. U., & Ro, J. Y. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-25 · Cited by 85
Oligodendroglia and neurotrophic factors in neurodegeneration
Bankston, A. N., Mandler, M. D., & Feng, Y. (2013) · Neuroscience Bulletin · doi:10.1007/s12264-013-1321-3 · Cited by 84
Inflammation as Therapeutic Objective in Stroke
Jordán, J., Segura, T., Brea, D., Galindo, M. F., & Castillo, J. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786848766 · Cited by 84
Simon, E., Obst, J., & Gomez-Nicola, D. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2018.01.059 · Cited by 83
Microglia produce and hydrolyze palmitoylethanolamide
Muccioli, G. G., & Stella, N. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.05.015 · Cited by 83
Chan‐Ling, T., Hughes, S., BAXTER, L., Rosinova, E., McGregor, I. S., Morcos, Y., van Nieuwenhuyzen, P. S., & Hu, P. (2007) · Microcirculation · doi:10.1080/10739680601073451 · Cited by 82
Role of Mast Cells in Regulation of T Cell Responses in Experimental and Clinical Settings
Komi, D. E. A., & Grauwet, K. (2017) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-017-8646-z · Cited by 82
Evidence for mast cells contributing to neuromuscular pathology in an inherited model of ALS
Trías, E., Ibarburu, S., Barreto‐Núñez, R., Varela, V., Moura, I. C., Dubreuil, P. C., Hermine, O., Beckman, J. S., & Barbeito, L. (2017) · JCI Insight · doi:10.1172/jci.insight.95934 · Cited by 82
Knerlich‐Lukoschus, F., von der Ropp‐Brenner, B., Lucius, R., Mehdorn, H. M., & Held‐Feindt, J. (2011) · Journal of Neurosurgery Spine · doi:10.3171/2010.12.spine10480 · Cited by 81
Central Nervous System Mast Cells in Peripheral Inflammatory Nociception
Xanthos, D. N., Gaderer, S., Drdla-Schutting, R., Nuro, E., Abramova, A., Ellmeier, W., & Sandkühler, J. (2011) · Molecular Pain · doi:10.1186/1744-8069-7-42 · Cited by 81
Allan, D., Fairlie‐Clarke, K. J., Elliott, C., Schuh, C., Barnett, S. C., Lassmann, H., Linington, C., & Jiang, H. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0344-1 · Cited by 81
Kempuraj, D., Selvakumar, G. P., Zaheer, S. A., Thangavel, R., Ahmed, M. E., Raikwar, S. P., Govindarajan, R., Iyer, S. S., & Zaheer, A. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-017-9766-1 · Cited by 81
Masitinib for the treatment of mild to moderate Alzheimer’s disease
Folch, J., Petrov, D., Ettcheto, M., Pedrós, I., Abad, S., Beas-Zarate, C., Lazarowski, A., Marin, M., Olloquequi, J., Auladell, C., et al. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1045419 · Cited by 80 · cited 1×
“It is currently in Phase II/III clinical trials for the treatment AD (Folch et al., 2015).”
BackgroundInvolvement of mast cells in a mouse model of postoperative pain
Oliveira, S. M., Drewes, C. C., Silva, C. R., Trevisan, G., Boschen, S. L., Moreira, C. G., Cabrini, D. A., Cunha, C. D., & Ferreira, J. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.10.001 · Cited by 80
Depression in Patients with Mastocytosis: Prevalence, Features and Effects of Masitinib Therapy
Moura, D. S., Sultan, S., Georgin‐Lavialle, S., Pillet, N., Montestruc, F., Gineste, P., Barète, S., Damaj, G. L., Moussy, A., Lortholary, O., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026375 · Cited by 79
Astrocyte-Microglia Cooperation in the Expression of a Pro-Inflammatory Phenotype
Barbierato, M., Facci, L., Argentini, C., Marinelli, C., Skaper, S. D., & Giusti, P. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113129990064 · Cited by 79
Self-citationZhang, X., Lund, H., Mia, S., Parsa, R., & Harris, R. A. (2014) · Glia · doi:10.1002/glia.22643 · Cited by 78
Roser, A.-E., Tönges, L., & Lingor, P. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00094 · Cited by 77 · cited 4×
“In addition to small molecule anti-inflammatory agents derived by synthetic chemical routes (Roser et al., 2017), tissue damage and/or stimulation of inflammatory responses activate endogenous protective mechanisms that lead to the elaboration of lipid mediators which function as a program of resolution to switch off…”
BackgroundInfluentialStroke Induces Histamine Accumulation and Mast Cell Degranulation in the Neonatal Rat Brain
Biran, V., Cochois, V., Karroubi, A., Arrang, J., Charriaut‐Marlangue, C., & Héron, A. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00092.x · Cited by 77
Punzo, D., Errico, F., Cristino, L., Sacchi, S., Keller, S., Belardo, C., Luongo, L., Nuzzo, T., Imperatore, R., Florio, E., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.3881-15.2016 · Cited by 77
Ribeiro, A., Pontis, S., Mengatto, L., Armirotti, A., Chiurchiù, V., Capurro, V., Fiasella, A., Nuzzi, A., Romeo, E., Moreno‐Sanz, G., et al. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00114 · Cited by 75
P2 receptors, microglial cytokines and chemokines, and neuropathic pain
Tsuda, M. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23816 · Cited by 74
The possible role of the kynurenine pathway in anhedonia in adolescents
Gabbay, V., Ely, B. A., Babb, J. S., & Liebes, L. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0685-7 · Cited by 73
Nakano, N., Nishiyama, C., Kanada, S., Niwa, Y., Shimokawa, N., Ushio, H., Nishiyama, M., Okumura, K., & Ogawa, H. (2007) · Blood · doi:10.1182/blood-2006-09-045641 · Cited by 73
Role of mast cell activation in inducing microglial cells to release neurotrophin
Yuan, H., Zhu, X., Zhou, S., Chen, Q., Zhu, X., Ma, X., He, X., Tian, M., & Shi, X. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22304 · Cited by 73
Olsson, N., Siegbahn, A., & Nilsson, G. P. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9911 · Cited by 72
Acetylcholine receptors from human muscle as pharmacological targets for ALS therapy
Palma, E., Reyes‐Ruiz, J. M., Lopergolo, D., Roseti, C., Bertollini, C., Ruffolo, G., Cifelli, P., Onesti, E., Limatola, C., Miledi, R., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600251113 · Cited by 71
APP Regulates Microglial Phenotype in a Mouse Model of Alzheimer's Disease
Manocha, G. D., Floden, A. M., Rausch, K., Kulas, J. A., McGregor, B. A., Rojanathammanee, L., Puig, K. L., Puig, K. L., Karki, S., Nichols, M. R., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.4654-15.2016 · Cited by 71
Strbian, D., Tatlisumak, T., Ramadan, U. A., & Lindsberg, P. J. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600387 · Cited by 70
Mixed organic brain syndrome as a manifestation of systemic mastocytosis.
Rogers, M. P., Bloomingdale, K. L., Murawski, B. J., Soter, N. A., Reich, P., & Austen, K. F. (1986) · Psychosomatic Medicine · doi:10.1097/00006842-198607000-00006 · Cited by 70
Tsilioni, I., Dodman, N. H., Petra, A. I., Taliou, A., Francis, K., Moon-Fanelli, A. A., Shuster, L., & Theoharides, T. C. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.106 · Cited by 69
Kolbinger, F., Huppertz, C., Mir, A. K., & Padova, F. E. D. (2016) · Current Drug Targets · doi:10.2174/1389450117666160307144027 · Cited by 69
Novel targets in Alzheimer’s disease: A special focus on microglia
Balducci, C., & Forloni, G. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.01.017 · Cited by 66
Harcha, P. A., Vargas, A., Yi, C., Koulakoff, A., Giaume, C., & Sáez, J. C. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.3686-14.2015 · Cited by 65
Constandil, L., Aguilera, R., Goich, M., Hernández, A., Álvarez, P., Infante, C., & Pélissier, T. (2011) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.08.008 · Cited by 64
Cells and Signaling in Oligodendrocyte Development
Grinspan, J. B. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.4.297 · Cited by 64
Communication between human mast cells and CD 4+ T cells through antigen‐dependent interactions
Suurmond, J., van Heemst, J., van Heiningen, J., Dorjée, A. L., Schilham, M. W., van der Beek, F. B., Huizinga, T. W. J., Schuerwegh, A. J., & Toes, R. E. M. (2013) · European Journal of Immunology · doi:10.1002/eji.201243058 · Cited by 63
Malamud, V., Vaaknin, A., Abramsky, O., Mor, M., Burgess, L. E., Ben‐Yehudah, A., & Lorberboum‐Galski, H. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00090-0 · Cited by 63
Calcium signalling in cells of oligodendroglial lineage
Soliven, B. C. (2001) · Microscopy Research and Technique · doi:10.1002/jemt.1051 · Cited by 63
Mast cells in chronic inflammation, pelvic pain and depression in women
Graziottin, A., Skaper, S. D., & Fusco, M. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.911280 · Cited by 63
Self-citationNeuropathic pain: Etiology, pathophysiology, mechanisms, and evaluations
Jay, G. W., & Barkin, R. L. (2014) · Disease-a-Month · doi:10.1016/j.disamonth.2013.12.001 · Cited by 63
Mast cells mediate neutrophil recruitment during atherosclerotic plaque progression
Wezel, A., Lagraauw, H. M., van der Velden, D., de Jager, S. C. A., Quax, P. H. A., Kuiper, J., & Bot, I. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.05.028 · Cited by 61
Roles of fatty acid ethanolamides (FAE) in traumatic and ischemic brain injury
Esposito, E., Cordaro, M., & Cuzzocrea, S. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.05.009 · Cited by 61
Kim, D. Y., Jeoung, D., & Ro, J. Y. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000991 · Cited by 60
Brain Under Stress and Alzheimer’s Disease
Mravec, B., Horváthová, Ľ., & Padová, A. (2017) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-017-0521-1 · Cited by 60
Orefice, N. S., Alhouayek, M., Carotenuto, A., Montella, S., Barbato, F., Comelli, A., Calignano, A., Muccioli, G. G., & Orefice, G. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0420-z · Cited by 58
Klein, K., Aeschlimann, A., Jordan, S., Gay, R., Gay, S., & Sprott, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036693 · Cited by 57
Ultra-micronized Palmitoylethanolamide: An Efficacious Adjuvant Therapy for Parkinson’s Disease
Brotini, S., Schievano, C., & Guidi, L. (2017) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527316666170321124949 · Cited by 57
Giorno, R. D., Skaper, S. D., Paladini, A., Varrassi, G., & Coaccioli, S. (2015) · Pain and Therapy · doi:10.1007/s40122-015-0038-6 · Cited by 56
Self-citationMeningeal mast cell-T cell crosstalk regulates T cell encephalitogenicity
Russi, A. E., Caulfield, M. E., Guo, Y. X., Lucchinetti, C. F., & Brown, M. A. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.06.015 · Cited by 56
Age-Induced Reprogramming of Mast Cell Degranulation
Nguyen, M., Pace, A. J., & Koller, B. H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.5701 · Cited by 55
Important role of mast cells in multiple sclerosis
Conti, P., & Kempuraj, D. (2015) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2015.11.005 · Cited by 54
Neurotrophic factors and their inhibitors in chronic pain treatment
Kelleher, J. H., Tewari, D., & McMahon, S. B. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.03.025 · Cited by 53
Pietrzak, A., Wierzbicki, M., Wiktorska, M., & Brzezińska‐Błaszczyk, E. (2011) · Mediators of Inflammation · doi:10.1155/2011/427473 · Cited by 52
Locci, A., Geoffroy, P., Miesch, M., Mensah-Nyagan, A.-G., & Pinna, G. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00208 · Cited by 52
Innate immunity and cellular senescence: The good and the bad in the developmental and aged brain
Santoro, A., Spinelli, C. C., Martucciello, S., Nori, S. L., Capunzo, M., Puca, A. A., & Ciaglia, E. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0118-003r · Cited by 50 · cited 2×
“…of Frontiers in Cellular Neuroscience | www.frontiersin.org 13 March 2018 | Volume 12 | Article 72 resident microglia (and astrocytes) might thus contribute to the age-related increase in risk for neurodegenerative diseases (Hoeijmakers et al., 2016; Labzin et al., 2018; Santoro et al., 2018).”
BackgroundCytokine and Immune System Abnormalities in Fibromyalgia and Other Central Sensitivity Syndromes
Staud, R. M. (2015) · Current Rheumatology Reviews · doi:10.2174/1573397111666150619094819 · Cited by 50
(2017) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/s-0043-104029 · Cited by 50
Serum amyloid A (SAA)-induced remodeling of CSF-HDL
Miida, T., Yamada, T., Seino, U., Ito, M., Fueki, Y., Takahashi, A., Kosuge, K., Soda, S., Hanyu, O., Obayashi, K., et al. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.03.013 · Cited by 49
Corticotropin-Releasing Hormone, Microglia and Mental Disorders
Kritas, S. K., Saggini, A., Cerulli, G. G., Caraffa, A., Antinolfi, P., Pantalone, A., Rosati, M., Tei, M. M., Speziali, A., Saggini, R., et al. (2014) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201402700203 · Cited by 49
Hayashi, R., Xiao, W., Kawamoto, M., Yuge, O., & Bennett, G. J. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0072181 · Cited by 48
Theoharides, T. C., Asadi, S., Panagiotidou, S., & Weng, Z. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.06.018 · Cited by 48
Amyloid β Peptides Trigger CD47-Dependent Mast Cell Secretory and Phagocytic Responses
Niederhoffer, N., Levy, R., Sick, É., André, P., Coupin, G., Lombard, Y., & Gies, J. (2009) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200902200224 · Cited by 48
Li, N., Zhang, X., Dong, H., Hu, Y., & Qian, Y. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.01.006 · Cited by 48
Maślińska, D., Laure‐Kamionowska, M., Maslinski, K. T., Gujski, M., & Maśliński, S. (2007) · Inflammation Research · doi:10.1007/s00011-006-0508-8 · Cited by 47
Nelson, R. B., Siman, R. G., Iqbal, M. A., & Potter, H. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb02160.x · Cited by 47
Human Mast Cells Stimulate Activated T Cells: Implications for Multiple Sclerosis
Theoharides, T. C., Kempuraj, D., Kourelis, T., & Manola, A. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1418.029 · Cited by 47
Antonucci, N., Cirillo, A., & Siniscalco, D. (2015) · Case Reports in Psychiatry · doi:10.1155/2015/325061 · Cited by 47
Potential analgesic effects of a novel N-acylethanolamine acid amidase inhibitor F96 through PPAR-α
Yang, L., Li, L., Chen, L., Li, Y., Chen, H., Li, Y., Ji, G., Lin, D., Liu, Z., & Qiu, Y. (2015) · Scientific Reports · doi:10.1038/srep13565 · Cited by 47
Rentzos, M., Rombos, A., Nikolaou, C., Zoga, M., Zouvelou, V., Dimitrakopoulos, A., Alexakis, T., Tsoutsou, A., Samakovli, A., Michalopoulou, M., et al. (2010) · European Neurology · doi:10.1159/000287582 · Cited by 46
Neurovascular Aspects of Amyotrophic Lateral Sclerosis
Oliveira, M. C., Hernandez‐Ontiveros, D. G., Louis, M. K., Willing, A. E., Borlongan, C. V., Sanberg, P. R., Voltarelli, J. C., & Garbuzova-Davis, S. N. (2012) · International review of neurobiology · doi:10.1016/b978-0-12-386986-9.00004-1 · Cited by 46
Lozada, A. F., Maegele, M., Stark, H., Neugebauer, E., & Panula, P. (2005) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2004.00622.x · Cited by 45
Apolipoprotein Serum Amyloid A in Alzheimer's Disease
Kindy, M. S., Yu, J., Guo, J., & Zhu, H. (1999) · Journal of Alzheimer s Disease · doi:10.3233/jad-1999-1303 · Cited by 44
Xie, F., Zhang, J.-C., Han, F., & Chen, J. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1486 · Cited by 44
Mast cell activation by myelin through scavenger receptor
Medic, N., Vita, F., Abbate, R., Soranzo, M. R., Pacor, S., Fabbretti, E., Borelli, V., & Zabucchi, G. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.05.019 · Cited by 44
Stokely, M. E., & Orr, E. L. (2008) · Journal of Neurotrauma · doi:10.1089/neu.2007.0397 · Cited by 43
Relevance of chronic stress and the two faces of microglia in Parkinson's disease
Herrera, A. J., Espinosa-Oliva, A. M., Carrillo-Jiménez, A., Oliva-Martín, M. J., García-Revilla, J., García-Quintanilla, A., de Pablos, R. M., & Venero, J. L. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00312 · Cited by 42
Iuvone, T., Affaitati, G., Filippis, D. D., Lopopolo, M., Grassia, G., Lapenna, D., Negro, L., Costantini, R., Vaia, M., Cipollone, F., et al. (2015) · Pain · doi:10.1097/j.pain.0000000000000220 · Cited by 42
Bushell, T. J. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.129577 · Cited by 41
TNF Increases Expression of IL-4 and PARs in Mast Cells
Zhang, H., Yang, H., & He, S. (2010) · Cellular Physiology and Biochemistry · doi:10.1159/000320556 · Cited by 41
Levy, D., Edut, S., Baratz-Goldstein, R., Rubovitch, V., Defrin, R., Bree, D., Gariépy, H. D. B., Zhao, J., & Pick, C. G. (2015) · Cephalalgia · doi:10.1177/0333102415617412 · Cited by 41
Mast cell inflammasome activity in the meninges regulates EAE disease severity
Russi, A. E., Caulfield, M. E., & Brown, M. A. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.04.009 · Cited by 41
Indraccolo, U., Indraccolo, S. R., & Mignini, F. (2017) · Annali dell Istituto Superiore di Sanità · doi:10.4415/ann_17_02_08 · Cited by 41
Pundir, P., MacDonald, C. A., & Kulka, M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401348 · Cited by 40
Barbierato, M., Borri, M., Facci, L., Zusso, M., Skaper, S. D., & Giusti, P. (2017) · Scientific Reports · doi:10.1038/s41598-017-12529-7 · Cited by 40
Self-citationYuan, B., Fu, F., Huang, S., Lin, C., Yang, G., Ma, K., Shi, H. R., & Yang, Z. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0141-7 · Cited by 38
Kempuraj, D., Thangavel, R., Fattal, R., Pattani, S., Yang, E., Zaheer, S. A., Santillan, D. A., Santillan, M. K., & Zaheer, A. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1790-z · Cited by 35
Nonneuronal Central Mechanisms of Pain
Romero-Sandoval, E. A., & Sweitzer, S. M. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2014.11.007 · Cited by 34
Amyotrophic Lateral Sclerosis Treatment with Ultramicronized Palmitoylethanolamide: A Case Report
Clemente, S. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311201070933 · Cited by 32
Chronobiology of the Neuroimmunoendocrine System and Aging
Maté, I., Madrid, J. A., & la Fuente, M. D. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140130201131 · Cited by 32
Effect of cerebral ischemia on brain mast cells in rats
Hu, W., Li-sha, X., Pan, J., Zheng, X., & Chen, Z. (2004) · Brain Research · doi:10.1016/j.brainres.2004.05.109 · Cited by 31
Sakamoto, A., Andoh, T., & Kuraishi, Y. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.01.008 · Cited by 29
Jang, S. Y., Shin, Y. K., Lee, H. Y., Park, J. Y., Suh, D. J., Kim, J. K., Bae, Y., & Park, H. T. (2012) · Glia · doi:10.1002/glia.22382 · Cited by 27
Mast cell activation is characterized by upregulation of a functional anaphylatoxin C5a receptor
Soruri, A., Grigat, J., Kiafard, Z., & Zwirner, J. (2008) · BMC Immunology · doi:10.1186/1471-2172-9-29 · Cited by 25
Glial cells as drug targets: What does it take?
Möller, T., & Boddeke, H. W. G. M. (2016) · Glia · doi:10.1002/glia.22993 · Cited by 25
Neuroprotective effect of masitinib in rats with postischemic stroke
Kocić, I., Kowiański, P., Rusiecka, I., Lietzau, G., Mansfield, C. D., Moussy, A., Hermine, O., & Dubreuil, P. C. (2014) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-014-1061-6 · Cited by 24
Yang, H., Wei, J., Zhang, H., Song, W., Wei, W., Zhang, L., Qian, K., & He, S. (2010) · Cellular Physiology and Biochemistry · doi:10.1159/000320557 · Cited by 24
Cadot, P., Hensel, P., Bensignor, E. J., Darmon-Hadjaje, C., Marignac, G., Beco, L., Fontaine, J., Jamet, J., Georgescu, G., CAMPBELL, K. L., et al. (2011) · Veterinary Dermatology · doi:10.1111/j.1365-3164.2011.00990.x · Cited by 23
Inflammation triggers production of dimethylsphingosine from oligodendrocytes
Chen, Y.-J., Hill, S. L., Huang, H., Taraboletti, A., Cho, K., Gallo, R. L., Manchester, M., Shriver, L. P., & Patti, G. J. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.08.011 · Cited by 21
A Practical Guide for Treatment of Pain in Patients with Systemic Mast Cell Activation Disease
Molderings, G. J. (2017) · Pain Physician · doi:10.36076/ppj.20.5.e849 · Cited by 21
Chirchiglia, D., Chirchiglia, P., & Signorelli, F. (2017) · Neurologia i Neurochirurgia Polska · doi:10.1016/j.pjnns.2017.11.002 · Cited by 20
Impact of Mast Cells on Multiple Sclerosis: Inhibitory Effect of Natalizumab
Kritas, S. K., Saggini, A., Cerulli, G. G., Caraffa, A., Antinolfi, P., Pantalone, A., Rosati, M., Tei, M. M., Speziali, A., Saggini, R., et al. (2014) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201402700303 · Cited by 17
Interleukin-17A expression in human synovial mast cells in rheumatoid arthritis and osteoarthritis
Kan, J.-I., Mishima, S., Kashiwakura, J., Sasaki-Sakamoto, T., Seki, M., Saito, S., Ra, C., Tokuhashi, Y., & Okayama, Y. (2016) · Allergology International · doi:10.1016/j.alit.2016.04.007 · Cited by 17
Cited by
Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway
Zusso, M., Lunardi, V., Franceschini, D., Pagetta, A., Lo, R., Stifani, S., Frigo, A. C., Giusti, P., & Moro, S. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1538-9 · Cited by 534
Self-citationAcylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials
Dambrova, M., Makrecka-Kuka, M., Kuka, J., Vilskersts, R., Nordberg, D., Attwood, M. M., Smesny, S., Sen, Z. D., Guo, A. C., Oler, E., et al. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000408 · Cited by 507
Cell-cell communication: New insights and clinical implications
Su, J., Song, Y., Zhu, Z., Huang, X., Fan, J., Qiao, J., & Mao, F. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01888-z · Cited by 433
The S100B story: from biomarker to active factor in neural injury
Michetti, F., D'Ambrosi, N., Toesca, A., Puglisi, M. A., Serrano, A., Marchese, E., Corvino, V., & Geloso, M. C. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14574 · Cited by 410
Gut microbial molecules in behavioural and neurodegenerative conditions
Needham, B. D., Kaddurah-Daouk, R., & Mazmanian, S. K. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-00381-0 · Cited by 379
Metadata
- Authors
- Skaper, S. D., Facci, L., Zusso, M., & Giusti, P.
- Venue
- Frontiers in Cellular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2018-03-21
- Volume
- 12
- Pages
- 72-72
- ISSN
- 1662-5102 (ISSN-L)
- OpenAlex
- W2790464514
- Cited by
- 457
- References
- 403
- FWCI
- 20.69
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.